To come to this finding, researchers tracked CLABSIs for one year at a 1,200 bed hospital center. They monitored 209 ICU beds and flagged patients moved to the ICU for a CLABSI contracted in a non-ICU setting.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Of 136 patients and 156 CLABSIs:
- 57 patients were treated for hematological malignancy.
- The device utilization ratio — number of catheter days divided by number of patient days — was 0.27.
- 76 percent of CLABSIs occurred with a tunneled line.
- 21 percent of CLABSIs occurred with a peripherally inserted central catheter.
- Total mortality was 23 percent.
In addition, researchers noted CLABSI rates were significantly higher in non-ICU settings and were associated with significant mortality, with patients treated for HM having the highest mortality.
More Articles on Infection Control & Clinical Quality:
AAMC Releases Guide to Evaluating Public Report Card Quality
Postoperative Pain Control Linked to Patient Satisfaction
ACS’ Online Tool Helps Predict Postoperative Complications
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
